Publicaciones en las que colabora con Ángel Carracedo Álvarez (21)

2024

  1. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

    Scientific Reports, Vol. 14, Núm. 1

  2. Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations

    Biomedicines, Vol. 12, Núm. 6

  3. Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases

    Best Practice and Research: Clinical Rheumatology

2023

  1. HLA alleles: important pieces to the COVID-19 puzzle

    Trends in Immunology

  2. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19

    HLA, Vol. 102, Núm. 6, pp. 731-739

2021

  1. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy

    Cancer Chemotherapy and Pharmacology, Vol. 88, Núm. 5, pp. 813-823

2020

  1. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

    Journal of Chemotherapy, pp. 1-13

  2. Interaction between the functional SNP rs2070951 in NR3C2 gene and high levels of plasma corticotropin-releasing hormone associates to postpartum depression

    Archives of Women's Mental Health, Vol. 23, Núm. 3, pp. 413-420

2019

  1. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment

    Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715

2014

  1. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families

    Clinical Genetics, Vol. 85, Núm. 6, pp. 583-588

2013

  1. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

    PLoS ONE, Vol. 8, Núm. 7

2012

  1. COGENT (COlorectal cancer GENeTics) revisited

    Mutagenesis, Vol. 27, Núm. 2, pp. 143-151

  2. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

    Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315

  3. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients

    International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 1, pp. 138-144

2010

  1. Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: Germline mutations in TP53 and PTEN

    Clinical Genetics

2009

  1. Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: A different spectrum of mutations?

    BMC Medical Genetics, Vol. 10

2006

  1. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis

    Journal of Rheumatology, Vol. 33, Núm. 6, pp. 1048-1051

2004

  1. Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects

    Arthritis and Rheumatism, Vol. 50, Núm. 8, pp. 2590-2597

2003

  1. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility

    Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382

  2. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease

    Journal of Rheumatology, Vol. 30, Núm. 1, pp. 102-104